参芪抑癌注射液治疗中晚期原发性肝癌90例临床观察

Clinical Observation on 90 Cases of Patients with Intermediate and Advanced Primary Liver Carcinoma Treated by Shenqi Yiai Injection

用参芪抑癌注射液治疗中晚期原发性肝癌，并与化疗作对照。治疗组能改善以气滞血瘀为主的原发性肝癌的症候，提高生存质量，延长生存期，对癌灶有一定缓解作用。总疗效为６２％，明显优于对照组（Ｐ＜０．０１）。

Primary liver carcinoma was treated by Shenqi Yiai injection in comparion with a conventional chemotherapy as a control. The injection was able to mitigate the syndrome of primary liver carcinoma with qi and blood stasis, improve life qualily, prolong survival time and exhibit focus, with an therapeutic effect on the cancer. The general effective rate being 62%. The injection was more potent than the control group (p<0.01)